# Costa Rica Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Costa Rica HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Costa Rica (CRI)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $93.5M
- Products: 21
- Buyer markets: 23
- Average CAGR: +20.7%
- Global sector size: $514.1B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $288.9B | $2.8M | $103.0B | -7.4% | 19 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $49.3B | $934.9K | $18.0B | +108.8% | 6 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $27.8B | $350.4K | $18.0B | +11.0% | 10 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $14.8B | $143.7K | $14.1B | +54.4% | 5 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $24.8B | $2.1M | $13.1B | +63.7% | 5 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $20.3B | $78.4K | $11.0B | -14.8% | 6 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $84.1M | $10.6B | +28.6% | 3 | +1.1% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $13.4B | $83.5K | $8.5B | +19.4% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $18.7B | $2.0M | $8.3B | +19.1% | 5 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $68.5K | $8.0B | -2.1% | 4 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $118.1 | $5.0B | -20.8% | 3 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $4.4B | $218.4K | $4.9B | +190.9% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $57.9K | $2.2B | +17.9% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $60.0K | $2.0B | +14.4% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $195.9K | $1.9B | +57.2% | 1 | +0.0% |
| HS 380893 - Herbicides, anti-sprouting products and plant-growth regulators: not containing substances of 3808.50: put up in forms or packings for retail sale or as preparations or articles | $2.0B | $293.6K | $1.7B | +19.6% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $86.9 | $1.4B | -15.2% | 1 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $4.7K | $1.3B | +13.1% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $2.2K | $1.1B | +5.2% | 1 | +0.0% |
| HS 290250 - Cyclic hydrocarbons: styrene | $768.8M | $16.4K | $1.1B | +46.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $1.9K | $1.0B | -6.4% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $52.0B calculated opportunity across 13 products.
- Switzerland, Liechtenstein (CHE): $33.9B calculated opportunity across 3 products.
- Germany (DEU): $26.7B calculated opportunity across 10 products.
- Belgium (BEL): $17.0B calculated opportunity across 4 products.
- Netherlands (NLD): $16.4B calculated opportunity across 4 products.
- China (CHN): $15.4B calculated opportunity across 5 products.
- France (FRA): $10.1B calculated opportunity across 6 products.
- Spain (ESP): $9.8B calculated opportunity across 5 products.
- Mexico (MEX): $9.1B calculated opportunity across 5 products.
- Canada (CAN): $9.0B calculated opportunity across 5 products.
- United Kingdom (GBR): $8.8B calculated opportunity across 4 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.

## Growth stars

- HS 300214: +190.9% average CAGR, $4.9B calculated opportunity.
- HS 300215: +108.8% average CAGR, $18.0B calculated opportunity.
- HS 300212: +63.7% average CAGR, $13.1B calculated opportunity.
- HS 382319: +57.2% average CAGR, $1.9B calculated opportunity.
- HS 300220: +54.4% average CAGR, $14.1B calculated opportunity.
- HS 290250: +46.2% average CAGR, $1.1B calculated opportunity.
- HS 330210: +28.6% average CAGR, $10.6B calculated opportunity.
- HS 380893: +19.6% average CAGR, $1.7B calculated opportunity.
- HS 293499: +19.4% average CAGR, $8.5B calculated opportunity.
- HS 382200: +19.1% average CAGR, $8.3B calculated opportunity.

## Diversification opportunities

- HS 300490: 19 buyer markets, $103.0B calculated opportunity.
- HS 382499: 10 buyer markets, $18.0B calculated opportunity.
- HS 300215: 6 buyer markets, $18.0B calculated opportunity.
- HS 300439: 6 buyer markets, $11.0B calculated opportunity.
- HS 300220: 5 buyer markets, $14.1B calculated opportunity.
- HS 300212: 5 buyer markets, $13.1B calculated opportunity.
- HS 382200: 5 buyer markets, $8.3B calculated opportunity.
- HS 330499: 4 buyer markets, $8.0B calculated opportunity.
- HS 330210: 3 buyer markets, $10.6B calculated opportunity.
- HS 293499: 3 buyer markets, $8.5B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.